Video

RNA-Seq analysis identifies cell subtypes to use as models for corneal wound healing

At ARVO 2022 in Denver, Colorado, Timothy Blenkinsop, MD, presented “3D Eye Organoids with Distinct Cornea.” His presentation outlined how these organoids have developed sophisticated cornea structures.

At ARVO 2022 in Denver, Colorado, Timothy Blenkinsop, MD, presented “3D Eye Organoids with Distinct Cornea.” His presentation outlined how these organoids have developed sophisticated cornea structures.

Dr. Blenkinsop is an associate professor of ophthalmology, cell development and regenerative biology at the Black Family Stem Cell Institute at the Icahn School of Medicine at Mount Sinai.

This transcript has been lightly edited for clarity.

Hi, my name is Timothy Blenkinsop. I'm an associate professor at the Icahn School of Medicine at Mount Sinai and we're here presenting some of our exciting work on eye organoids.

And so one of the organoids that we developed are these organoids that differentiate into sophisticated cornea structures. We have conducted single cell RNA-Seq analysis and identified a number of different subtypes of cells, which resemble — at least in terms of the gene expression — the cell types of the cornea, and now we're using these for modeling wound healing diseases and testing compounds to see whether we can mitigate those symptoms from wound healing.

One of the objectives of this research is to develop an eye drop that a patient can use or when they're injured, that could hopefully minimize the wound healing response after injury.

The next step is really convincing the field at large that this is an effective model, and then moving into animals to then revalidate our proof of principle in animals.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.